Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Show simple item record

dc.contributor.author Klimek, L.
dc.contributor.author Jutel, M.
dc.contributor.author Akdis, C.
dc.contributor.author Bousquet, J.
dc.contributor.author Akdis, M.
dc.contributor.author Bachert, C.
dc.contributor.author Agache, I.
dc.contributor.author Ansotegui, I.
dc.contributor.author Bedbrook, A.
dc.contributor.author Bosnic-Anticevich, S.
dc.contributor.author Canonica, G. W.
dc.contributor.author Chivato, T.
dc.contributor.author Cruz, A. A.
dc.contributor.author Czarlewski, W.
dc.contributor.author Giacco, S. D.
dc.contributor.author Du, H.
dc.contributor.author Fonseca, J. A.
dc.contributor.author Gao, Y.
dc.contributor.author Haahtela, T.
dc.contributor.author Hoffmann-Sommergruber, K.
dc.contributor.author Ivancevich, J. C.
dc.contributor.author Khaltaev, N.
dc.contributor.author Knol, E. F.
dc.contributor.author Kuna, P.
dc.contributor.author Larenas-Linnemann, D.
dc.contributor.author Melen, E.
dc.contributor.author Mullol, J.
dc.contributor.author Naclerio, R.
dc.contributor.author Ohta, K.
dc.contributor.author Okamoto, Y.
dc.contributor.author O'Mahony, Liam
dc.contributor.author Onorato, G. L.
dc.contributor.author Papadopoulos, N. G.
dc.contributor.author Pawankar, R.
dc.contributor.author Pfaar, O.
dc.contributor.author Samolinski, B.
dc.contributor.author Schwarze, J.
dc.contributor.author Toppila-Salmi, S.
dc.contributor.author Shamji, M. H.
dc.contributor.author Ventura, M. T.
dc.contributor.author Valiulis, A.
dc.contributor.author Yorgancioglu, A.
dc.contributor.author Matricardi, P.
dc.contributor.author Zuberbier, T.
dc.contributor.author ARIA-MASK Study Group
dc.date.accessioned 2020-05-05T08:17:40Z
dc.date.available 2020-05-05T08:17:40Z
dc.date.issued 2020-04-24
dc.identifier.citation Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., Bachert, C., Agache, I., Ansotegui, I., Bedbrook, A., Bosnic-Anticevich, S., Canonica, G. W., Chivato, T., Cruz, A. A., Czarlewski, W., Giacco, S. D., Du, H., Fonseca, J. A., Gao, Y., Haahtela, T., Hoffmann-Sommergruber, K., Ivancevich, J. C., Khaltaev, N., Knol, E. F., Kuna, P., Larenas-Linnemann, D., Melen, E., Mullol, J., Naclerio, R., Ohta, K., Okamoto, Y., O'Mahony, L., Onorato, G. L., Papadopoulos, N. G., Pawankar, R., Pfaar, O., Samolinski, B., Schwarze, J., Toppila-Salmi, S., Shamji, M. H., Ventura, M. T., Valiulis, A., Yorgancioglu, A., Matricardi, P., Zuberbier, T. and the ARIA-MASK Study Group (2020) 'Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement', Allergy. doi: 10.1111/all.14336 en
dc.identifier.issn 0105-4538
dc.identifier.uri http://hdl.handle.net/10468/9896
dc.identifier.doi 10.1111/all.14336 en
dc.description.abstract The current COVID-19 pandemic influences many areas of social life, medical treatments and the way allergy is performed. Allergen-specific immunotherapy (AIT) is one of the most important treatment options for IgE-mediated allergies and is based on immunological effects on the diseased patient. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher John Wiley & Sons, Inc. en
dc.rights © 2020, John Wiley & Sons, Inc. This is the peer reviewed version of the following article: Klimek, L., Jutel, M., Akdis, C., Bousquet, J., Akdis, M., Bachert, C., Agache, I., Ansotegui, I., Bedbrook, A., Bosnic-Anticevich, S., Canonica, G. W., Chivato, T., Cruz, A. A., Czarlewski, W., Giacco, S. D., Du, H., Fonseca, J. A., Gao, Y., Haahtela, T., Hoffmann-Sommergruber, K., Ivancevich, J. C., Khaltaev, N., Knol, E. F., Kuna, P., Larenas-Linnemann, D., Melen, E., Mullol, J., Naclerio, R., Ohta, K., Okamoto, Y., O'Mahony, L., Onorato, G. L., Papadopoulos, N. G., Pawankar, R., Pfaar, O., Samolinski, B., Schwarze, J., Toppila-Salmi, S., Shamji, M. H., Ventura, M. T., Valiulis, A., Yorgancioglu, A., Matricardi, P., Zuberbier, T. and the ARIA-MASK Study Group (2020) 'Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement', Allergy, doi: 10.1111/all.14336, which has been published in final form at https://doi.org/10.1111/all.14336. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. en
dc.subject COVID-19 en
dc.subject Allergen-specific immunotherapy en
dc.subject AIT en
dc.title Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Liam O'Mahony, Medicine, University College Cork, Cork, Ireland. +353-21-490-3000 Email: liam.omahony@ucc.ie en
dc.internal.availability Full text available en
dc.check.info Access to this article is restricted until 12 months after publication by request of the publisher. en
dc.check.date 2021-04-24
dc.date.updated 2020-05-01T09:14:39Z
dc.description.version Accepted Version en
dc.internal.rssid 512556282
dc.internal.pmid 32329930
dc.description.status Peer reviewed en
dc.identifier.journaltitle Allergy en
dc.internal.copyrightchecked Yes
dc.internal.licenseacceptance Yes en
dc.internal.IRISemailaddress liam.omahony@ucc.ie en
dc.internal.bibliocheck In press. Check volume / issue / page range. Amend citation and copyright statement accordingly. en
dc.identifier.eissn 1398-9995


Files in this item

This item appears in the following Collection(s)

Show simple item record

This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement